Piet Jansen
Chief Tech/Sci/R&D Officer bei CARMAT
Profil
Piet Jansen is currently the Chief Medical Officer at Carmat SA since 2009.
Prior to this, he worked as the Chief Medical Officer & Managing Director-Europe at World Heart Corp.
from 2004 to 2009, Head-Research & Clinical Trials at Edwards Lifesciences Corp.
from 1997 to 2001, Vice President-Clinical Affairs at Jarvik Heart, Inc. from 2001 to 2003, and Vice President-Clinical Programs at Orqis International GmbH from 2003 to 2004.
He also worked as a Researcher at Rotterdam University.
Dr. Jansen holds a doctorate degree from both the University of Amsterdam and Radboud University Nijmegen.
Aktive Positionen von Piet Jansen
| Unternehmen | Position | Beginn |
|---|---|---|
| CARMAT | Chief Tech/Sci/R&D Officer | 23.12.2010 |
Ehemalige bekannte Positionen von Piet Jansen
| Unternehmen | Position | Ende |
|---|---|---|
World Heart Corp.
 World Heart Corp. Miscellaneous Commercial ServicesCommercial Services World Heart Corp. develops artificial heart and related technologies. The company was founded on April 1, 1996 and is headquartered in Salt Lake City, UT. | Chief Tech/Sci/R&D Officer | 28.12.2009 |
| Orqis International GmbH | Chief Tech/Sci/R&D Officer | 01.02.2004 |
Jarvik Heart, Inc.
 Jarvik Heart, Inc. Medical SpecialtiesHealth Technology Jarvik Heart, Inc. is a medical device company that develops miniaturized heart assist devices for the treatment of severe heart failure. The private company is based in New York, NY. The company's flagship product, the Jarvik 2000 Flowmaker, is an axial flow pump that moves blood out of the heart at an impressive flow rate and is designed to be as "forgettable" as an implanted device can be. The company also developed the Jarvik 15mm, a miniature heart assist device for infants and children. The company has participated in clinical trials and has a growing list of centers using their products worldwide. The CEO of the company is Robert Jarvik, who is widely known as the inventor of the first successful permanent artificial heart, the Jarvik 7. | Chief Tech/Sci/R&D Officer | 01.01.2003 |
| EDWARDS LIFESCIENCES CORPORATION | Chief Tech/Sci/R&D Officer | 01.01.2001 |
| Rotterdam University | Corporate Officer/Principal | - |
Ausbildung von Piet Jansen
| University of Amsterdam | Doctorate Degree |
| Radboud University Nijmegen | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| EDWARDS LIFESCIENCES CORPORATION | Health Technology |
| CARMAT | Health Technology |
| Private Unternehmen | 3 |
|---|---|
World Heart Corp.
World Heart Corp. Miscellaneous Commercial ServicesCommercial Services World Heart Corp. develops artificial heart and related technologies. The company was founded on April 1, 1996 and is headquartered in Salt Lake City, UT. | Commercial Services |
Jarvik Heart, Inc.
Jarvik Heart, Inc. Medical SpecialtiesHealth Technology Jarvik Heart, Inc. is a medical device company that develops miniaturized heart assist devices for the treatment of severe heart failure. The private company is based in New York, NY. The company's flagship product, the Jarvik 2000 Flowmaker, is an axial flow pump that moves blood out of the heart at an impressive flow rate and is designed to be as "forgettable" as an implanted device can be. The company also developed the Jarvik 15mm, a miniature heart assist device for infants and children. The company has participated in clinical trials and has a growing list of centers using their products worldwide. The CEO of the company is Robert Jarvik, who is widely known as the inventor of the first successful permanent artificial heart, the Jarvik 7. | Health Technology |
| Orqis International GmbH |
